Rare diseases
Investigational molecules
Locations
Back to Ireland324 clinical trials in Drogheda, Ireland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Vericiguat for Children with Heart Failure Due to Left Ventricular Systolic Dysfunction
IrelandStudy of Trimodulin for Adults Hospitalized with Severe Community-Acquired Pneumonia
IrelandStudy on Tranexamic Acid and Sodium Chloride for Patients with Stroke-Related Brain Bleeding
IrelandStudy on Ivosidenib for Patients with Previously Treated Advanced or Metastatic Cholangiocarcinoma
IrelandStudy on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency-Related Liver Disease and Fibrosis
IrelandStudy on the Safety and Effectiveness of TransCon CNP for Children and Adolescents with Achondroplasia
IrelandStudy to Compare Fianlimab and Cemiplimab Combination with Pembrolizumab in Patients with High-Risk Melanoma After Surgery
IrelandStudy on Long-Term Safety and Effectiveness of Vanzacaftor, Tezacaftor, and Deutivacaftor for Cystic Fibrosis in Patients Aged 1 Year and Older
IrelandPhase III Trial Comparing ABVD vs A2VD Treatment With PET-Guided Radiation Therapy for Patients With Early Stage Hodgkin Lymphoma
IrelandStudy on ONC201 and Everolimus with Radiotherapy for Newly Diagnosed Diffuse Intrinsic Pontine Glioma and Other Diffuse Midline Gliomas in Children, Adolescents, and Adults
IrelandStudy on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia
IrelandStudy of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy
IrelandThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on inflammatory bowel diseases, including trials evaluating new therapeutic approaches for ulcerative colitis and Crohn's disease. Studies are examining novel compounds like obefazimod for improving patient outcomes.
Multiple trials are investigating endoscopic improvement and symptomatic remission in patients with moderate to severe conditions.
Groundbreaking research in preventing and treating various infections, with particular focus on Clostridioides difficile infection recurrence and surgical site infections following abdominal procedures.
Studies are evaluating novel preventive measures and treatment approaches to reduce infection rates.
Clinical research examining treatments for chronic skin conditions, with emphasis on Hidradenitis Suppurativa. Trials are evaluating new biological therapies like lutikizumab for moderate to severe cases.
Research focuses on improving symptoms and quality of life for patients with persistent skin disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
